Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 and related stress may increase hair loss known as Telogen effluvium.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

Start acne treatment early to prevent scarring, consider antibiotic resistance, use maintenance therapy, and manage side effects carefully.

Anesthesia and surgery can cause temporary hair loss, but hair usually grows back without treatment.

The "color-transition sign" helps tell apart alopecia areata incognita from telogen effluvium by looking at hair color changes.

A teenager's hair with alternating white and dark bands, known as Pili annulati, is a genetic condition that is usually harmless and often considered attractive.

Hair loss from telogen effluvium may not happen again after another surgery.

A patient experienced intense hair loss due to telogen effluvium after scalp contact dermatitis, but hair regrew completely within two months without further treatment.

A specially designed molybdenum oxide nanozyme can treat and monitor acute kidney injury effectively.

A young Persian cat had a skin infection and low platelets, treated with various medications.

Middle-aged women with chronic telogen effluvium experience increased hair shedding but usually don't get significantly thinner hair.

The normal range for the hair pull test is 2 hairs or fewer, and washing or brushing hair before the test does not affect the results.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

Nickel, cobalt, balsam of Peru, fragrance mix, carba mix, and propylene glycol are common allergens causing scalp contact dermatitis.

Lactoferrin levels are lower in people with chronic hair shedding, suggesting supplements could help treat it.

The herbal extract was found to effectively reduce and prevent hair loss without any side effects.

Wiesbaden 30C effectively reduces hair fall and improves hair growth in young adults with Telogen Effluvium.

A woman lost over 80% of her hair due to a condition called telogen effluvium after having COVID-19.

A patient's hair loss after a browlift surgery improved on its own over 8 months.

Ethanamizuril is safe for rats at 20 mg/kg feed, but higher doses cause hair loss, organ changes, and liver, kidney, and lung damage.

Composite flaps are better than muscle-only flaps for long-term skull coverage.

Isotretinoin's effects and side effects, like birth defects and depression, might be due to it causing cell death in various cells.

Burn reconstruction improves with new techniques, materials, and tissue engineering.

Men with baldness have higher levels of specific proteins, suggesting local hormone production may play a role in hair loss.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.

The tumescent technique improves hair micrografting by providing lasting anesthesia, reducing bleeding, and increasing patient comfort.

Two people lost a lot of hair because of epilepsy drugs, but their hair grew back after changing medication.

The study found that a specific signaling pathway helps skin wounds heal faster but may lead to larger scars.